SCHEMBL26638982

SCHEMBL26638982

Cc1nc(-c2cc(C(=O)O)n(C)n2)cs1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4A O75164 1/20 0.50
▸ KDM4B O94953 1/20 0.50
▸ KDM5C P41229 1/20 0.50
▸ KDM5B Q9UGL1 1/20 0.50
▸ ECE1 P42892 3/20 0.49
▸ KDM4E B2RXH2 3/20 0.47
▸ RAB9A P51151 3/20 0.47
▸ POLB P06746 2/20 0.47
▸ GAA P10253 2/20 0.47
▸ HTT P42858 1/20 0.47
▸ GRN P28799 1/20 0.44
▸ SORT1 Q99523 1/20 0.44
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26638882 0.74 KDM4A (0.48) KDM4AKDM4BKDM5CKDM5BECE1
SCHEMBL1815173 0.71 ALPL (0.53) KDM4AKDM4BKDM5CKDM5BECE1
SCHEMBL30722885 0.70 PTPN1 (0.50) KDM4EGRNSORT1CA12CA1
SCHEMBL26639107 0.70 KDM4E (0.44) ECE1KDM4EGRNSORT1CA12
SCHEMBL24359598 0.70 GAA (0.52) KDM4AKDM4BKDM5CKDM5BECE1
SCHEMBL2792109 0.69 PHGDH (0.61) CA12CA1CA2CA9PTPN1
SCHEMBL286931 0.69 KDM4E (0.58) KDM4EPOLBGAAHTTGRN
SCHEMBL15265584 0.69 KDM4E (0.43) KDM4EPOLBGRNSORT1CA12
SCHEMBL26659258 0.68 KDM4E (0.49) KDM4AKDM5CKDM4EGRNSORT1
SCHEMBL6494629 0.68 KDM4E (0.51) KDM4AKDM5CKDM4ERAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12565494-B2 Inhibitors of human respiratory syncytial virus and metapneumovirus MERCK SHARP & DOHME LLC 2026-03-03 — — US disclosed
US-20230365551-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2023-11-16 — — US disclosed
WO-2023220225-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2023-11-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365551-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS NHERF1, ACE, METAP1 KDM4A 4244/4885KDM4B 4099/4885KDM5C 4575/4885
US-12565494-B2 Inhibitors of human respiratory syncytial virus and metapneumovirus NHERF1, ZC3HAV1, SARS1 KDM4A 3945/4885KDM4B 3834/4885KDM5C 3734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback